We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXT icon
1851
Crane NXT
CXT
$2.96B
$713K ﹤0.01%
34,954
RIGL icon
1852
Rigel Pharmaceuticals
RIGL
$766M
$713K ﹤0.01%
22,220
EPR icon
1853
EPR Properties
EPR
$4.74B
$711K ﹤0.01%
12,980
AL
1854
DELISTED
Air Lease Corp
AL
$702K ﹤0.01%
20,700
-1,529
-7% -$57.9K
DBC icon
1855
Invesco DB Commodity Index Tracking Fund
DBC
$1.71B
$702K ﹤0.01%
39,000
-12,360
-24% -$220K
NSIT icon
1856
Insight Enterprises
NSIT
$4.58B
$698K ﹤0.01%
23,350
EWU icon
1857
iShares MSCI United Kingdom ETF
EWU
$4.13B
$690K ﹤0.01%
18,900
-22,250
-54% -$851K
SGMO
1858
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$689K ﹤0.01%
62,100
+12,000
+24% +$155K
UTX.PRA
1859
DELISTED
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
$686K ﹤0.01%
11,900
TTWO icon
1860
Take-Two Interactive
TTWO
$45B
$685K ﹤0.01%
24,845
VRE
1861
DELISTED
Veris Residential
VRE
$684K ﹤0.01%
37,134
SHLM
1862
DELISTED
Schulman (A.) Inc
SHLM
$683K ﹤0.01%
15,613
NWBI icon
1863
Northwest Bancshares
NWBI
$2.32B
$680K ﹤0.01%
53,079
CTRX
1864
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$678K ﹤0.01%
11,094
-141,638
-93% -$8.5M
VISN
1865
Vistance Networks Inc
VISN
$2.71B
$677K ﹤0.01%
22,200
UBSI icon
1866
United Bankshares
UBSI
$6.7B
$672K ﹤0.01%
16,700
OVTI
1867
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$672K ﹤0.01%
25,670
+189
+0.7% +$5.06K
WLK icon
1868
Westlake Corp
WLK
$10.2B
$668K ﹤0.01%
9,742
DWRE
1869
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
$668K ﹤0.01%
9,400
-57,716
-86% -$3.72M
BOH icon
1870
Bank of Hawaii
BOH
$3.14B
$665K ﹤0.01%
9,966
+3,200
+47% +$202K
DNR
1871
DELISTED
Denbury Resources, Inc.
DNR
$659K ﹤0.01%
103,577
+50,600
+96% +$386K
MDU icon
1872
MDU Resources
MDU
$4.31B
$658K ﹤0.01%
88,603
MPT
1873
Medical Properties Trust
MPT
$2.44B
$657K ﹤0.01%
50,100
ESSA
1874
DELISTED
ESSA Bancorp
ESSA
$655K ﹤0.01%
50,900
CIE
1875
DELISTED
Cobalt International Energy, Inc
CIE
$652K ﹤0.01%
4,473

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.